Last updated: February 13, 2026
What is the current market status of the drug NDC 00078-0946?
NDC 00078-0946 corresponds to Methylprednisolone Sodium Succinate for Injection, 40 mg per vial. It is a corticosteroid used primarily for conditions requiring rapid anti-inflammatory action, such as severe allergic reactions, adrenal insufficiency, and certain autoimmune disorders.
The drug is marketed by West-Ward Pharmaceuticals LLC, a generic drug manufacturer. It competes with other corticosteroid formulations and biosimilars, with availability in both hospital and outpatient settings.
Market share remains stable in the corticosteroid injection segment, which experienced increased demand during the COVID-19 pandemic for inflammatory response management but has normalized post-pandemic.
Pricing varies by supplier, location, and purchasing volume. The average wholesale price (AWP) in the U.S. ranges from approximately $7.00 to $10.00 per vial, with retail and hospital procurement prices typically 30-50% lower.
What are the key market segments and geographic considerations?
Market Segments:
- Hospitals and infusion centers: Major purchasers due to inpatient use.
- Outpatient clinics: Used in emergency settings and outpatient procedures.
- Pharmaceutical wholesalers/distributors: Central hubs for supply chain distribution.
Geographic regions:
- United States: Largest market, driven by hospital and outpatient sector.
- Global markets: Smaller and variable demand in Europe, Asia, and Latin America, often aligned with local regulatory approvals and healthcare infrastructure.
How does competition impact the price?
The corticosteroid injectable segment faces competition from brands such as Pfizer’s Solu-Medrol and several generic equivalents. Biosimilars are limited due to the drug’s chemical nature but may influence future pricing dynamics.
Competitive factors:
- Biosimilar entry: No biosimilars available for methylprednisolone sodium succinate.
- Generic price elasticity: Sensitive to manufacturing costs and regulatory actions.
- Supply chain disruptions: Can cause short-term price fluctuations.
What are the price projections over the next 5 years?
Assumptions:
- No significant new generic entrants.
- Stable demand in current markets.
- No major regulatory or manufacturing disruptions.
| Year |
Estimated Wholesale Price per Vial |
Explanation |
| 2023 |
$7.00 – $10.00 |
Current range, varies by supplier |
| 2024 |
$6.50 – $9.75 |
Slight downward pressure due to increased competition |
| 2025 |
$6.50 – $9.50 |
Stabilization, slight decrease expected |
| 2026 |
$6.50 – $9.50 |
Market saturation, steady prices |
| 2027 |
$6.50 – $9.25 |
Marginal decline if manufacturing efficiencies improve |
Factors influencing future prices:
- Manufacturing efficiencies: Can reduce costs and lower prices.
- Regulatory changes: Price controls or new policies may impact pricing.
- Market demand shifts: Variations in clinical practice patterns.
- Global economic factors: Currency fluctuations, supply chain costs.
Summary of risks and opportunities
- Risks: Entry of biosimilar or new generics, regulatory environment changes, supply chain disruptions.
- Opportunities: Expansion into international markets, formulation innovations, or new indications.
Key Takeaways
- The current U.S. wholesale price range is $7.00–$10.00 per vial.
- Market demand remains stable, with prices expected to decline slightly through 2027.
- Competitive landscape is driven primarily by generics; biosimilar development is unlikely due to chemical complexity.
- Price variability depends on supply chain stability and healthcare policy changes.
- International markets could see different pricing dynamics depending on regulatory approval and healthcare infrastructure.
FAQs
1. How does the competition affect the price of NDC 00078-0946?
The scarcity of biosimilars and multiple generics keeps prices relatively stable, with slight downward adjustments due to competition among suppliers.
2. Are there upcoming regulatory changes that may impact pricing?
Possible price control policies at federal or state levels could influence market dynamics, but no major legislative shifts are currently anticipated.
3. How does supply chain disruption influence price?
Supply chain issues can cause short-term price spikes, especially if manufacturing or distribution is delayed.
4. What is the impact of international markets on global pricing?
Pricing in Europe, Asia, and Latin America varies significantly; regulatory approvals and healthcare system differences shape prices more distinctly outside the U.S.
5. What are the potential growth areas for this drug?
Expansion in international markets and new clinical indications could create additional demand rather than new price increases in existing markets.
Sources:
[1] U.S. Medicaid Drug Rebate Program, FDA Drug Labeling, and pricing reports (2023).
[2] IQVIA and SSR Health, 2023.
[3] U.S. healthcare policy and pricing analysis reports (2023).
